
    
      The institutional review board approved this retrospective study at a public academic medical
      center. The monthly volume of breast biopsies and breast cancers during the COVID-19 pandemic
      (between January 1 and July 31, 2020) was compared to the same period a year earlier
      (pre-COVID-19).
    
  